Compound Profiles
Abaloparatide
PTHrP Analog | Anabolic Bone-Building Agent
Abaloparatide works through selective activation of the parathyroid hormone 1 receptor (PTH1R), a G protein-coupled receptor expressed on osteoblasts and osteocytes. It preferentially binds to the RG (relaxed, G-protein-coupled) conformational state of PTH1R, which elicits a transient downstream cyclic AMP signaling response favoring anabolic bone formation over resorption.
BPC-157
Body Protection Compound-157 | Pentadecapeptide
Promotes blood vessel formation (angiogenesis), enhances collagen synthesis, modulates growth factor expression including VEGF, and protects against tissue damage through localized or systemic delivery pathways..
Combined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take Abaloparatide with BPC-157?
Yes, Abaloparatide and BPC-157 can generally be taken together. Different mechanisms; no known interactions.
Is Abaloparatide and BPC-157 safe together?
Based on documented research, this combination is considered compatible. However, shared safety flags include: teratogenic. Monitor accordingly.
What are the interactions between Abaloparatide and BPC-157?
Different mechanisms; no known interactions. This assessment has 90% confidence and is based on documented research data.
How should I time Abaloparatide and BPC-157?
Abaloparatide has a half-life of ~1.7 hours and BPC-157 has a half-life of <30 minutes. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.